AMERICAN NATUROPATHIC RESEARCH INSTITUTE
NATUROPATHIC ONCOLOGY RESEARCH INSTITUTE
1250 E. Baseline Rd., Suite 205
Tempe, AZ 85283
JOINT MEETING OF THE
AMERICAN NATUROPATHIC RESEARCH INSTITUTE (ANRI)
NATUROPATHIC ONCOLOGY RESEARCH INSTITUTE (NORI)
INTERNATIONAL NATUROPATHIC CLINICAL RESEARCH INSTITUTE
INSTITUTIONAL REVIEW BOARD (IRB)
August 12, 2016
MINUTES AND MEETING NOTES
In accordance with the requirements of the United States Code of Federal Regulations, Title 21, Chapter 1, Subchapter A, Part 56, the twenty-sixth regular quarterly meeting of the American Naturopathic Research Institute (ANRI) and the Naturopathic Oncology Research Institute (NORI) and the International Naturopathic Clinical Research Institute (INCRI) and the Institutional Review Board (IRB) was called to order at 12:00 p.m., August 12, 2016 at 1250 E. Baseline Rd., Suite 205, meeting in Suite 203, Tempe, AZ 85283.
MEMBERS AND GUESTS
15 members and guests were in attendance. This included 11 physicians and 4 non-physicians.
We discussed a case of Stage 4 breast cancer, refractory to treatment in London, went to Mexico, finally here to Arizona. It turned out that nobody had diagnosed an infected subclavian PICC line until the patient arrived here to Arizona. When the PICC was removed, the heart rate went from 110 to 70. The naturopathic physician diagnosed also an infected tooth. After it was pulled, the patient improved. The patient has not yet had lumpectomy or mastectomy.
The next case was a 50 yo female, very healthy, who then developed a near-fatal cardiac condition. Thermography of the head showed an inflamed gum surrounding a decayed tooth, with infection continuing to the jaw. After the tooth was pulled, the patient improved. Thermography showed that infection pooled in gums under this one tooth.
Another case was presented of a dedifferentiated chondrosarcoma, where the MD is using Ivermectin, an anti-parasite drug with a longer history of veterinary use. The patient has come far from his terminal diagnosis, and is now doing quite a bit better. One doctor suggested fibrinolytic enzymes and heparin in this case. Another doctor suggested using a good palliative care company, when administration of therapies to hospice patients becomes politically charged.
PRODUCT COMPOUNDING AND REGULATORY MATTERS
Against the background of the late 2015 Congressional instruction to the FDA to stop over-reaching in the physician-patient relationship, that such over-reach of authority by the FDA was never intended by the Drug Quality and Security Act (DQSA),
And given Health and Human Services (HHS) Secretary Sylvia Burwell announcing that compounding, including by traditional compounders “should be occurring,” and that the FDA did not need to prohibit it. — Even despite these good events, there are recent concerning actions by the FDA.
Recently, the FDA has responded by issuing documentation on 8/3/16, attempting to specifically delineate restrictions on compounding. These were discussed at length.
Various strengths of compounding physicians in defense of the treatments that our patients need were also discussed.
Dr. Proefrock will give a presentation for the AZNMA on Compounding and issues related to it. This is scheduled for September 14.
We are also in discussion with Neisha Winters, ND of Colorado, to come to give us a lecture on the use of mistletoe. We are expecting this to happen two weeks from today on Friday, August 26.
‘COMPOUNDING PHYSICIANS’ TRADEMARK
ANRI / NORI’s application to the US Patent and Trademark Office (USPTO) was rejected. We had applied for the trademark to “Compounding Physicians,” but this was rejected as “too generic.” We found some encouragement in that it implied a tacit understanding that compounding is something that physicians (also) do. We decided not to pursue re-applying with a more specific qualifier before “Compounding Physicians.”
It was mentioned that it takes only $10 to file a trademark in Arizona for 10 years of trademark protection.
HEALTH INSURANCE VS HEALTH SHARING
OOne of the physicians re-introduced the group to an alternative to conventional health insurance. This is approved by the ACA, and exempts participants from the tax penalty for not having insurance. Some of the companies offering this are: Solidarity Health Shares, Liberty Health Shares, and Ministry Health Shares.
Basically, these offer exactly what many of us and like-minded people have been looking for: naturopathic plus catastrophic coverage. The premium is about $150 per person per month. For catastrophic events, the coverage is up to $1,000,000. Also, enrollment is always open, not just during one season.
AZ NATUROPATHIC BOARD
5 of the 7 positions on the Board have had their terms expire. After asking Gail Anthony about that, G Anthony responded that the Governor has yet to appoint replacements to the Board.
HAZEL CHANDLER’S BOOK DESCRIBING HER CANCER JOURNEY
This book has been several drafts in the making. It is now available on Amazon. Hazel has offered to donate a sizeable portion of the proceeds from the sales to Naturopathic Cancer Society, which is a 501c3 non-profit that is dedicated to honoring patient choices in cancer treatment.
We are so appreciative of Hazel presenting the case for inclusion of naturopathic medicine in the platform of one of the major political parties this year prior to their convention.
We agreed to meet again next time on Friday, November 4, 2016– usual time and place.
Meeting adjourned at 3:15 p.m.